Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Expert recommendations 2006 on the rationale for second-line therapy for non-small cell bronchial neoplasms].
Hilbe W, Aigner K, Dittrich C, Eckmayr J, Fiegl M, Flicker M, Forstner B, Greil R, Jamnig H, Krajnik G, Lang A, Mohn-Staudner A, Schinko H, Studnicka M, Pirker R, Ploner F, Rothmund J, Schiller L, Zabernigg A, Zöchbauer-Müller S. Hilbe W, et al. Wien Klin Wochenschr. 2007;119(7-8):259-66. doi: 10.1007/s00508-007-0792-5. Wien Klin Wochenschr. 2007. PMID: 17492355 Review. German. No abstract available.
[Small cell lung cancer].
Hoschek S, Hoschek-Risslegger U, Fiegl M, Zabernigg A, Pall G, Auberger T, Gunsilius E, Schmid T, Jamnig H, Hilbe W; Tiroler Arbeitskreis für Onkologie TAKO. Hoschek S, et al. Among authors: hilbe w. Wien Klin Wochenschr. 2007;119(23-24):697-710. doi: 10.1007/s00508-007-0913-1. Wien Klin Wochenschr. 2007. PMID: 18157602 Review. German.
[Updated strategies in Small Cell Lung Cancer post ASCO 2007].
Hoschek S, Hoschek-Risslegger U, Fiegl M, Zabernigg A, Pall G, Auberger T, Gunsilius E, Schmid T, Jamnig H, Hilbe W. Hoschek S, et al. Among authors: hilbe w. Wien Med Wochenschr. 2007;157(21-22):562-8. doi: 10.1007/s10354-007-0484-9. Wien Med Wochenschr. 2007. PMID: 18157594 Review. German.
[Histology-based algorithm in the molecular diagnosis of mutations of the Epidernal Growth Factor Receptor (EGFR) in non-small cell lung cancer].
Popper H, Wrba F, Gruber-Mösenbacher U, Hulla W, Pirker R, Hilbe W, Studnicka M, Mohn-Staudner A, Ploner F; und die Arbeitsgruppe Pulmopathologie der ÖGP-IAP. Popper H, et al. Among authors: hilbe w. Wien Klin Wochenschr. 2011 May;123(9-10):316-21. doi: 10.1007/s00508-011-1573-8. Epub 2011 May 31. Wien Klin Wochenschr. 2011. PMID: 21604158 German.
Biomarkers in non-small cell lung cancer prevention.
Hilbe W, Dirnhofer S, Greil R, Wöll E. Hilbe W, et al. Eur J Cancer Prev. 2004 Oct;13(5):425-36. doi: 10.1097/00008469-200410000-00011. Eur J Cancer Prev. 2004. PMID: 15452456 Review.
Multicenter phase II study evaluating docetaxel and cisplatin as neoadjuvant induction regimen prior to surgery or radiochemotherapy with docetaxel, followed by adjuvant docetaxel therapy in chemonaive patients with NSCLC stage II, IIIA and IIIB (TAX-AT 1.203 Trial).
Kocher F, Pircher A, Mohn-Staudner A, Romeder F, Duller W, Steinmaurer M, Eckmayr J, Schmid T, Hilbe W, Fiegl M, Greil R. Kocher F, et al. Among authors: hilbe w. Lung Cancer. 2014 Sep;85(3):395-400. doi: 10.1016/j.lungcan.2014.06.019. Epub 2014 Jul 3. Lung Cancer. 2014. PMID: 25043642 Clinical Trial.
129 results